Cargando…

Native T1 mapping in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study

Detalles Bibliográficos
Autores principales:	Fontana, Marianna, Banypersad, Sanjay M, Treibel, Thomas A, Maestrini, Viviana, Sado, Daniel, White, Steven K, Castelletti, Silvia, Herrey, Anna S, Hawkins, Philip N, Moon, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043793/ http://dx.doi.org/10.1186/1532-429X-16-S1-O4

Ejemplares similares

AL and ATTR cardiac amyloid are different: native T1 mapping and ECV detect different biology
por: Fontana , Marianna, et al.
Publicado: (2014)

Cardiac amyloid burden assessment by T1 mapping predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study
por: Banypersad, Sanjay M, et al.
Publicado: (2014)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
por: Karamitsos, Theodoros, et al.
Publicado: (2012)

LGE-PSIR is an independent predictor of mortality in cardiac amyloidosis: a 250 patient prospective study
por: Fontana, Marianna, et al.
Publicado: (2015)

Quality of life in ATTR amyloidosis
por: Lane, Thirusha, et al.
Publicado: (2015)

Multiorgan ECV as measured by EQ-MRI in systemic amyloidosis
por: Banypersad, Sanjay M, et al.
Publicado: (2013)

Diflunisal therapy for cardiac ATTR amyloidosis: a longitudinal, prospective, single centre study
por: Quarta, Candida C, et al.
Publicado: (2015)

Cardiac involvement in cardiac AL amyloidosis as measured by equilibrium contrast cardiovascular magnetic resonance
por: Banypersad, Sanjay M, et al.
Publicado: (2012)

ATTR Amyloidosis: development of cardiac symptoms during 6 years of follow up in different ATTR-variants
por: Klaassen, Sebastiaan, et al.
Publicado: (2015)

Conventional heart failure therapy in cardiac ATTR amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2023)

T1 mapping and survival in systemic light-chain amyloidosis
por: Banypersad, Sanjay M., et al.
Publicado: (2015)

Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis
por: Treibel, Thomas A., et al.
Publicado: (2015)

Updates in Cardiac Amyloidosis: A Review
por: Banypersad, Sanjay M., et al.
Publicado: (2012)

Multi-modality imaging in cardiac ATTR amyloidosis: agreement between echocardiography, MRI and DPD-scintigraphy
por: Eliahou, Ludivine, et al.
Publicado: (2015)

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
por: Dungu, Jason, et al.
Publicado: (2012)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Cardiac amyloidosis: diagnostic challenges and recent advancement in the treatment of transthyretin amyloidosis (ATTR)
por: Rahman, Tanvir, et al.
Publicado: (2021)

Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years
por: Ioannou, Adam, et al.
Publicado: (2022)

Native T1 lowering in iron overload and Anderson Fabry disease; a novel and early marker of disease
por: Sado, Daniel, et al.
Publicado: (2013)

Diagnosis and Treatment of AL and ATTR Amyloidosis
por: Faiman, Beth, et al.
Publicado: (2021)

Deep Learning to Classify AL versus ATTR Cardiac Amyloidosis MR Images
por: Germain, Philippe, et al.
Publicado: (2023)

Unusual case of ATTR amyloidosis with cardiac manifestation and situs inversus totalis
por: Fritschka, Max, et al.
Publicado: (2017)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Guidelines for genetic counselling in ATTR amyloidosis
por: Sequeiros, Jorge
Publicado: (2015)

Heart transplantation in hereditary ATTR amyloidosis
por: Slama, M
Publicado: (2015)

Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis
por: Smorti, Martina, et al.
Publicado: (2023)

Prevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement
por: Scully, Paul R., et al.
Publicado: (2018)

Analysis of disease progression in patients with transthyretin cardiac amyloidosis
por: Gilmore, Julian D, et al.
Publicado: (2015)

T1 mapping for myocardial extracellular volume measurement by cardiovascular magnetic resonance: bolus only vs primed infusion technique
por: White, Steven K, et al.
Publicado: (2013)

Cardiac Amyloidosis: Updates in Imaging
por: Chacko, Liza, et al.
Publicado: (2019)

Variable myocardial interstitial expansion by T1 mapping within LGE area in infarction and hypertrophic cardiomyopathy
por: Maestrini, Viviana, et al.
Publicado: (2013)

A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis)
por: Gonzalez-Duarte, Alejandra, et al.
Publicado: (2021)

Myocardial Work Does Not Have Additional Diagnostic Value in the Assessment of ATTR Cardiac Amyloidosis
por: Henein, Michael Y., et al.
Publicado: (2021)

Interstitial expansion in pressure overload left ventricular hypertrophy
por: Treibel, Thomas A, et al.
Publicado: (2013)

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy
por: Adams, David, et al.
Publicado: (2020)

A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes Survey
por: González-Moreno, Juan, et al.
Publicado: (2021)

Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV Amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2023)

Imaging-Guided Treatment for Cardiac Amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2022)

Interstitial expansion in health and disease - an equilibrium contrast CMR study
por: Sado, Daniel, et al.
Publicado: (2012)

Myocardial strain in a health and disease: CMR feature tracking analysis in cardiac hypertrophy
por: Barison, Andrea, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pp3p6du8fcngdqjnfjjnu2q506